Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The complement system plays a paradoxical role in the development and expression of autoimmunity in humans. The activation of complement in systemic lupus erythematosus (SLE) contributes to tissue injury. In contrast, inherited deficiency of classical pathway components, particularly C1q (ref. 1), is powerfully associated with the development of SLE. This leads to the hypothesis that a physiological action of the early part of the classical pathway protects against the development of SLE (ref. 2) and implies that C1q may play a key role in this respect. C1q-deficient (C1qa-/-) mice were generated by gene targeting and monitored for eight months. C1qa-/- mice had increased mortality and higher titres of autoantibodies, compared with strain-matched controls. Of the C1qa-/- mice, 25% had glomerulonephritis with immune deposits and multiple apoptotic cell bodies. Among mice without glomerulonephritis, there were significantly greater numbers of glomerular apoptotic bodies in C1q-deficient mice compared with controls. The phenotype associated with C1q deficiency was modified by background genes. These findings are compatible with the hypothesis that C1q deficiency causes autoimmunity by impairment of the clearance of apoptotic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Casciola-Rosen, L. A., Anhalt, G., & Rosen, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1317 · Cited by 1,717
Korb, L. C., & Ahearn, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4525 · Cited by 657
Casciola-Rosen, L., Rosen, A., Petri, M., & Schlissel, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1624 · Cited by 482
Baker, A. J., Mooney, A., Hughes, J., Lombardi, D., Johnson, R. J., & Savill, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117565 · Cited by 404
LeFeber, W. P., Norris, D. A., Ryan, S. R., Huff, J. C., Lee, L. A., Kubo, M., Boyce, S. T., Kotzin, B. L., & Weston, W. L. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111569 · Cited by 335
Complement deficiency and disease
Morgan, B. P., & Walport, M. J. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90003-c · Cited by 302
Self-citationNovel packages of viral and self-antigens are generated during apoptosis.
Rosen, A., Casciola-Rosen, L., & Ahearn, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1557 · Cited by 246
Hereditary C1q deficiency and systemic lupus erythematosus
(1994) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068955 · Cited by 207
Self-citationGolan, T. D., Elkon, K. B., Gharavi, A. E., & Krueger, J. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115922 · Cited by 165
Subnucleosome structures as substrates in enzyme-linked immunosorbent assays
Burlingame, R. W., & Rubin, R. L. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90380-e · Cited by 124
Cited by
Items 201–300 of 1,000
Emerging and Novel Functions of Complement Protein C1q
Kouser, L., Madhukaran, S. P., Shastri, A., Saraon, A., Ferluga, J., Al-Mozaini, M., & Kishore, U. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00317 · Cited by 175
“Furthermore, C1q−/− mice are unable to clear apoptotic trophoblasts whose accumulation can result in abnormal placentation (92).”
BackgroundNatural IgM: Beneficial Autoantibodies for the Control of Inflammatory and Autoimmune Disease
Grönwall, C., & Silverman, G. J. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0025-4 · Cited by 175
“, sIgM −/−) or MBL or C1q, all display marked impairment in their capacity for apoptotic cell clearance with spontaneous accumulations of apoptotic cells [43–46].”
BackgroundMehlhop, E., & Diamond, M. S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052388 · Cited by 175
A protective role for innate immunity in systemic lupus erythematosus
Carroll, M. C. (2004) · Nature Reviews Immunology · doi:10.1038/nri1456 · Cited by 175
Bondanza, A., Zimmermann, V. S., Rovere-Querini, P., Turnay, J., Dumitriu, I. E., Stach, C. M., Voll, R. E., Gaipl, U. S., Bertling, W., Pöschl, E., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040327 · Cited by 175
“Intriguingly, the failure in the function of M is involved in the pathogenesis of the prototypic autoimmune disease systemic lupus erythematosus, and the defective clearance of dead cells associates to persistent autoimmunity in vivo (7, 44, 45).”
BackgroundThe Role of Complement in Danger Sensing and Transmission
Kohl, J. (2006) · Immunologic Research · doi:10.1385/ir:34:2:157 · Cited by 172
“The view of C1qcoating as an important physiological clearance mechanism for apoptotic cells is supported by the fact C1q-deficient mice show profound impairment in such clearance resulting in severe glomerulonephritis ( 30 ).”
BackgroundTGF-β: the perpetrator of immune suppression by regulatory T cells and suicidal T cells
Wahl, S. M., Swisher, J., McCartney-Francis, N., & Chen, W. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1103539 · Cited by 172
“Defects in apoptotic cell clearance have been directly linked to persistent inflammatory and autoimmune conditions in humans [96–98].”
BackgroundSchäfer, M. K.-H., Schwaeble, W. J., Post, C., Salvati, P., Calabresi, M., Sim, R. B., Petry, F., Loos, M., & Weihe, E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5446 · Cited by 172
“ated only in either C1q-deficient mouse strains (43) or using spe-”
MethodSelf-citationCutaneous lupus erythematosus: a review
Patel, P., & Werth, V. (2002) · Dermatologic Clinics · doi:10.1016/s0733-8635(02)00016-5 · Cited by 172
“Mice with homozygous C1q deficiency have been found spontaneously to develop high titers of ANA and glomerulonephritis coupled with the accumulation of apoptotic bodies in the glomeruli [24].”
Backgroundde Rycke, L., Baeten, D., Kruithof, E., Van den Bosch, F., Veys, E. M., & de Keyser, F. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21190 · Cited by 172
Paths reunited: Initiation of the classical and lectin pathways of complement activation
Wallis, R., Mitchell, D. A., Schmid, R., Schwaeble, W. J., & Keeble, A. H. (2010) · Immunobiology · doi:10.1016/j.imbio.2009.08.006 · Cited by 169
“It is also linked with defective clearance of immune complexes and cellular debris, leading to glomerulonephritis (Botto et al., 1998), and increased risk of autoimmune disease, particularly systemic lupus erythematosus (Lewis &”
BackgroundThe Role of Neutrophils and Monocytes in Innate Immunity
Kantari, C., Pederzoli-Ribeil, M., & Witko-Sarsat, V. (2008) · Contributions to Microbiology · doi:10.1159/000136335 · Cited by 169
Links between complement abnormalities and systemic lupus erythematosus
Pickering, M. C., & Walport, M. J. (2000) · Rheumatology · doi:10.1093/rheumatology/39.2.133 · Cited by 168
Self-citationMini‐review: A pivotal role for innate immunity in the clearance of apoptotic cells
Roos, A., Xu, W., Castellano, G., Nauta, A. J., Garred, P., Daha, M. R., & van Kooten, C. (2004) · European Journal of Immunology · doi:10.1002/eji.200424904 · Cited by 168
Ageing is associated with diminished apoptotic cell clearance in vivo
Aprahamian, T., Takemura, Y., Goukassian, D., & Walsh, K. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03658.x · Cited by 167
Nielsen, C. T., Østergaard, O., Stener, L., Iversen, L. V., Truedsson, L., Gullstrand, B., Jacobsen, S., & Heegaard, N. H. H. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34381 · Cited by 167
“Extrapolated to in vivo conditions, this suggests an increased load of apoptotic material that cannot be cleared in SLE patients, consistent with murine models of SLE (15).”
BackgroundInnate and adaptive immune response to apoptotic cells
Peng, Y., Martin, D. A., Kenkel, J., Zhang, K., Ogden, C. A., & Elkon, K. B. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.07.017 · Cited by 167
“For example, MFG-E8 facilitates apoptotic cell clearance in germinal centers [19] whereas C1q deficiency leads to apoptotic cell accumulation in the kidney [20].”
BackgroundPotter, P. K., Cortes-Hernandez, J., Quartier, P., Botto, M., & Walport, M. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3223 · Cited by 167
Self-citationWu, Y.-C., Tsai, M.-C., Cheng, L.-C., Chou, C.-J., & Weng, N.-Y. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00056-9 · Cited by 167
Quartier, P., Potter, P. K., Ehrenstein, M. R., Walport, M. J., & Botto, M. (2005) · European Journal of Immunology · doi:10.1002/eji.200425497 · Cited by 166
Self-citationPattern recognition receptors in the immune response against dying cells
Jeannin, P., Jaillon, S., & Delneste, Y. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.04.013 · Cited by 165
Complement C1q Reduces Early Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
Bhatia, V. K., Yun, S., Leung, V., Grimsditch, D. C., Benson, G. M., Botto, M. B., Boyle, J. J., & Haskard, D. O. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060406 · Cited by 165
“In both humans and mice, a consequence of C1q deficiency is the development of a systemic lupus erythematosus-like syndrome.(23,32) However, in mice this is dependent on genetic background, since C1qa / animals show no evidence of autoimmunity after backcrossing onto C57BL/6.”
BackgroundMethodSelf-citationGiles, K. M., Ross, K., Rossi, A. G., Hotchin, N. A., Haslett, C., & Dransfield, I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.976 · Cited by 164
“A number of cell surface molecules have been proposed to mediate the uptake of apoptotic cells; these include lectins (11),avb3 integrin/CD36/thrombospondin complex (12, 13), phosphatidylserine receptors (14), scavenger receptors (15), receptors for oxidized lipids (16), CD14 (17), CD29 (18), the ABC1 transporter (19)…”
BackgroundMaturation of dendritic cells abrogates C1q production in vivo and in vitro
Castellano, G., Woltman, A. M., Nauta, A. J., Roos, A., Trouw, L. A., Seelen, M. A., Schena, F. P., Daha, M. R., & van Kooten, C. (2004) · Blood · doi:10.1182/blood-2003-09-3046 · Cited by 164
Chen, Z., Koralov, S. B., & Kelsoe, G. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1339 · Cited by 164
“In some studies, wild-type B6/129 mice exhibit slightly higher levels of background autoantibody than do B6 mice (13).”
BackgroundMethodInfluentialFraser, D. A., Laust, A. K., Nelson, E. L., & Tenner, A. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902232 · Cited by 163
“It is well documented that C1q plays an important role in the clearance of apoptotic cells in vivo (9, 10), and in vitro it has been shown that C1q can enhance the uptake of apoptotic cells (11–13) and reviewed in Trouw et al.”
BackgroundIGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo
Ogden, C. A., Kowalewski, R., Peng, Y., Montenegro, V., & Elkon, K. B. (2005) · Autoimmunity · doi:10.1080/08916930500124452 · Cited by 163
“Double knockout mice were created by breeding the C1q and sIgM deficient strains and the genotypes confirmed by PCR analysis as described [3,6].”
MethodInnate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen
Link, A., Zabel, F., Schnetzler, Y., Titz, A., Brombacher, F., & Bachmann, M. F. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103312 · Cited by 162
“Natural Abs mediate transport of particulate Ag The physiologically most important activation of the classical complement pathway is initiated by binding of the globular domains of C1q to Ag-bound IgG or IgM.”
MethodInfluentialThe “ins and outs” of complement‐driven immune responses
Freeley, S., Kemper, C., & Le Friec, G. (2016) · Immunological Reviews · doi:10.1111/imr.12472 · Cited by 161
Phagocytosis of Apoptotic Cells by Macrophages From NOD Mice Is Reduced
O’Brien, B. A., Huang, Y., Geng, X., Dutz, J. P., & Finegood, D. T. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2481 · Cited by 161
Cutting Edge: Ectopic Expression of CD40 Ligand on B Cells Induces Lupus-Like Autoimmune Disease
Higuchi, T., Aiba, Y., Nomura, T., Matsuda, J., Mochida, K., Suzuki, M., Kikutani, H., Honjo, T., Nishioka, K., & Tsubata, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.9 · Cited by 160
“The severity of glomerulonephritis was graded according to the degree of deposition of PAS-positive substance, hypercellularity, and sclerotic change in glomeruli as described previously (18, 19), with slight modification.”
MethodBijl, M., Reefman, E., Horst, G., Limburg, P. C., & Kallenberg, C. G. M. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.035733 · Cited by 160
Retinal synthesis and deposition of complement components induced by ocular hypertension
Kuehn, M. H., Kim, C. Y., Ostojić, J., Bellin, M., Alward, W. L. M., Stone, E. M., Sakaguchi, D. S., Grozdanić, S. D., & Kwon, Y. H. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.03.002 · Cited by 160
“For example, inherited deficiencies of the classical complement pathway components, particularly C1q, are strongly associated with the development of systemic lupus erythematosus or glomerulonephritis presumably by causing autoimmunity through delayed or insufficient clearance of apoptotic cells (Botto et al., 1998).”
BackgroundGaipl, U. S., Kuenkele, S., Voll, R. E., Beyer, T. D., Kolowos, W., Heyder, P., Kalden, J. R., & Herrmann, M. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400826 · Cited by 159
“Mice with targeted disruption of the C1qa gene provided evidence that C1q is necessary for proper clearance of apoptotic cells, since apoptotic corpse accumulated in the kidneys of these animals.(31) Furthermore, it was shown that C1q binds to surface blebs of apoptotic keratinocytes.”
BackgroundInfluentialRacila, E. V., Link, B. K., Weng, W., Witzig, T. E., Ansell, S. M., Maurer, M. J., Huang, J., Dahle, C. E., Halwani, A. S., Levy, R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0745 · Cited by 159
Blebs and Apoptotic Bodies Are B Cell Autoantigens
Cocca, B. A., Cline, A. M., & Radic, M. Z. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.159 · Cited by 174
“Molecules that belong to this group and bind to blebs include the mannose-binding lectin (54), the complement collectin C1q (55), C-reactive protein (56), and SAP component (57).”
BackgroundInfluentialThe release of microparticles by apoptotic cells and their effects on macrophages
Distler, J. H. W., Huber, L. C., Hueber, A. J., Reich, C. F., Gay, S., Distler, O., & Pisetsky, D. S. (2005) · APOPTOSIS · doi:10.1007/s10495-005-2941-5 · Cited by 159
Update on human systemic lupus erythematosus genetics
Tsao, B. P. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000132648.62680.81 · Cited by 159
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target
Lou, H., Ling, G. S., & Cao, X. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102861 · Cited by 158
Kemper, C., Mitchell, L. M., Zhang, L., & Hourcade, D. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801015105 · Cited by 158
Chen, Y., Khanna, S., Goodyear, C. S., Park, Y. B., Raz, E., Thiel, S., Grönwall, C., Vas, J., Boyle, D. L., Corr, M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900948 · Cited by 158
“On the basis of evidence that humans with a homozygotic deficiency in C1q have a high penetrance of lupus-like systemic autoimmunity (55), studies of murine models confirmed this also occurs on certain genetic backgrounds and is associated with an accumulation of apoptotic bodies in the kidney and glomerulonephritis i…”
BackgroundInnate apoptotic immunity: the calming touch of death
Birge, R. B., & Ucker, D. S. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.58 · Cited by 171
A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen
Xue, D., Shi, H., Smith, J. D. S., Chen, X., Noe, D. A., Cedervall, T., Yang, D. D., Eynon, E. E., Brash, D. E., Kashgarian, M. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832411100 · Cited by 158
The cunning little vixen: Foxo and the cycle of life and death
Hedrick, S. M. (2009) · Nature Immunology · doi:10.1038/ni.1784 · Cited by 157
“A speculation is that a genetic polymorphism found in 129 mice acts together with the loss of Foxo3 to dysregulate T cell homeostasis and cause autoimmune diseas”
BackgroundGenetic dissection of systemic autoimmune disease in Nrf2-deficient mice
Li, J., Stein, T. D., & Johnson, J. A. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00209.2003 · Cited by 153
“This can occur by a decreased clearance of circulating DNA or other cellular components such as occurs in both mice and humans with a knockout of the DNA-degrading enzyme deoxyribonuclease I (37, 49) or the complement protein C1q (5, 43).”
BackgroundTas, S. W., Quartier, P., Botto, M., & Fossati‐Jimack, L. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.037143 · Cited by 168
Self-citationBenoit, M. E., Hernandez, M. X., Dinh, M. L., Benavente, F., Vasquez, O., & Tenner, A. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.400168 · Cited by 155
“The 3 TgBUB mice were then crossed to C1q knock-out mice (C1qa / ) (17), previously backcrossed to BUB/BnJ for six generations, generating 3 TgBUBC1q / mice (validated by PCR and/or qPCR and test breeding).”
MethodNorsworthy, P. J., Fossati-Jimack, L., Cortes-Hernandez, J., Taylor, P. R., Bygrave, A. E., Thompson, R. D., Nourshargh, S., Walport, M. J., & Botto, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3406 · Cited by 147
“Interestingly, the CD93-deficient mice, unlike the C1q-deficient mice (22), did not develop features of a lupus-like disease as assessed by renal histology and anti-ssDNA Abs (data not shown).”
BackgroundMethodSelf-citationYao, Z. Q., Nguyen, D. T., Hiotellis, A. I., & Hahn, Y. S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5264 · Cited by 155
“production (3), as well as the development of autoimmune disease (4).”
BackgroundSanter, D. M., Hall, B. E., George, T. C., Tangsombatvisit, S., Liu, C. L., Arkwright, P. D., & Elkon, K. B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001731 · Cited by 150
“The early classical complement proteins, C1q, C2, and C4, may act in a common pathway leading to the assembly of C3bi on apoptotic cells, which we, and others, previously showed is important for the clearance of dying cells (70, 71).”
BackgroundImmunoregulatory role of TNFα in inflammatory kidney diseases
Ernandez, T., & Mayadas, T. N. (2009) · Kidney International · doi:10.1038/ki.2009.142 · Cited by 165
Genetic dissection of systemic lupus erythematosus
Wakeland, E. K., Wandstrat, A. E., Liu, K., & Morel, L. M. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00039-4 · Cited by 151
Death, autoantigen modifications, and tolerance.
Utz, P. J., Gensler, T. J., & Anderson, P. (2000) · Arthritis Research · doi:10.1186/ar75 · Cited by 164
Intrarenal synthesis of complement
Zhou, W., Marsh, J. E., & Sacks, S. H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041227.x · Cited by 154
Shimada, M., Hernández, I., Gonzalez-Robanya, I., & Richards, J. S. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0194 · Cited by 155
C1q and MBL, components of the innate immune system, influence monocyte cytokine expression
Fraser, D. A., Bohlson, S. S., Jasinskiene, N., Rawal, N., Palmarini, G., Ruiz, S., Rochford, R., & Tenner, A. J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105683 · Cited by 143
“Indeed, the importance of the role of defense collagens in clearance of apoptotic cells is highlighted by studies in vivo of mice deficient in C1q, SPD, and MBL [16, 19, 20], in which mice exhibit impaired clearance of apoptotic cells.”
Backgroundda Silveira, S. A., Kikuchi, S., Fossati‐Jimack, L., Moll, T., Saito, T., Verbeek, J. S., Botto, M., Walport, M. J., Carroll, M. C., & Izui, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012024 · Cited by 154
“deficient mice were backcrossed for 10 and 5 generations with B6 mice, respectively (13, 14).”
BackgroundSelf-citationGoldbach‐Mansky, R. T. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04533.x · Cited by 156
The Classical and Regulatory Functions of C1q in Immunity and Autoimmunity
Lu, J., Teh, B. K., Wang, L., Wang, Y., Tan, Y. S., Lai, M. C., & Reid, K. B. M. (2008) · Cellular and Molecular Immunology · doi:10.1038/cmi.2008.2 · Cited by 148
“The report that SAP mice developed autoimmunity, like C1q mice, is consistent with its binding to AC and triggering of C1q-mediated complement activation (14, 91).”
BackgroundInfluentialMechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus
Cook, H. T., & Botto, M. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0191 · Cited by 159
“In order to further investigate this link, we generated mice with a targeted deletion of the gene encoding the C1qA chain”
MethodSelf-citationGilmour, J. S., Coutinho, A. E., Cailhier, J.-F., Man, T. Y., Clay, M., Thomas, G., Harris, H. J., Mullins, J. J., Seckl, J. R., Savill, J. S., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7605 · Cited by 143
CD46 Plays a Key Role in Tailoring Innate Immune Recognition of Apoptotic and Necrotic Cells
Elward, K., Griffiths, M., Mizuno, M., Harris, C. L., Neal, J. W., Morgan, B. P., & Gasque, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506579200 · Cited by 142
Lupus, DNase and defective disposal of cellular debris
Walport, M. J. (2000) · Nature Genetics · doi:10.1038/75963 · Cited by 146
Self-citationUnraveling the genetics of systemic lupus erythematosus
Harley, J. B., Kelly, J. A., & Kaufman, K. M. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0040-5 · Cited by 157
“apoptotic cells may provide the source of autoantigens that stimulate the autoantibody response [88].”
Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis
Berden, J. H. M., Licht, R., van Bruggen, M. C. J., & Tax, W. J. M. (1999) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-199905000-00005 · Cited by 144
Hauwel, M., Furon, E., Canova, C., Griffiths, M., Neal, J. W., & Gasque, P. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.012 · Cited by 167
Cunin, P., Beauvillain, C., Miot, C., Augusto, J.-F., Preisser, L., Blanchard, S., Pignon, P., Scotet, M., Garo, E., Fremaux, I., et al. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.113 · Cited by 131
“Moreover, SAP /− and C1q /− mice only develop autoimmunity on the mixed 129×C57BL/6 or MRL/Mp background.(30,31) To our knowledge, MFG-E8 /− mice are the only opsonin-deficient”
BackgroundMahoney, J. A., & Rosen, A. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.09.018 · Cited by 143
Genetic Influences on the End-Stage Effector Phase of Arthritis
Ji, H., Gauguier, D., Ohmura, K., Gonzalez, A., Duchatelle, V., Danoy, P., Garchon, H.-J., Degott, C., Lathrop, M., Benoist, C., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.3.321 · Cited by 144
“Alternatively, members of an immunologically relevant multigene family could be at the root, different members exerting divergent influences on the immune system processes underlying autoimmunity, or the convergence might reflect different consequences of the same genetic event, much as mutations affecting lytic prope…”
BackgroundBao, L., Osawe, I., Puri, T., Lambris, J. D., Haas, M., & Quigg, R. J. (2005) · European Journal of Immunology · doi:10.1002/eji.200526327 · Cited by 142
“For example, C1q-deficient mice develop higher titers of autoantibodies and GN with greater number of glomerular apoptotic bodies due to impaired clearance [ 49 ].”
BackgroundHeasman, S., Giles, K., Ward, C., Rossi, A., Haslett, C., & Dransfield, I. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780029 · Cited by 141
Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer’s disease
Zhou, J., Fonseca, M. I., Pisalyaput, K., & Tenner, A. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05558.x · Cited by 130
“For example, it is known that C1q enhances phagocytosis (Bobak et al. 1987; Botto et al. 1998; Mitchell et al. 1999) (and reviewed in Bohlson et al.”
BackgroundMethodInfluentialHart, S. P., Ross, J. A., Ross, K., Haslett, C., & Dransfield, I. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400680 · Cited by 142
Mehlhop, E., Ansarah-Sobrinho, C., Johnson, S., Engle, M. J., Fremont, D. H., Pierson, T. C., & Diamond, M. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.09.015 · Cited by 141
Regulatory Roles for CD14 and Phosphatidylinositol in the Signaling via Toll-like Receptor 4-MD-2
Akashi, S., Ogata, H., Kirikae, F., Kirikae, T., Kawasaki, K., Nishijima, M., Shimazu, R., Nagai, Y., Fukudome, K., Kimoto, M., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2089 · Cited by 158
Etiopathogenesis of systemic lupus erythematosus
i, M. H., Voll, R. E., & Kalden, J. R. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01675-3 · Cited by 140
Cohen, J. I., Roychowdhury, S., McMullen, M. R., Stavitsky, A. B., & Nagy, L. E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.041 · Cited by 138
Liver X receptors as regulators of macrophage inflammatory and metabolic pathways
A-González, N., & Castrillo, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.015 · Cited by 139
“Also, some groups of patients with systemic lupus erythematosus (SLE) present both in vitro and in vivo deficiencies in their ability to clear apoptotic cells [172].”
BackgroundMultiple facets of macrophages in renal injury
Kluth, D., Erwig, L., & Rees, A. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00773.x · Cited by 145
“component, leads to generation of autoantibodies and in a proportion of mice the spontaneous development of glomerulonephritis with increased local apoptotic bodies [58].”
BackgroundMcColl, A., Bournazos, S., Franz, S., Perretti, M., Morgan, B. P., Haslett, C., & Dransfield, I. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803503 · Cited by 135
“Serum, from coagulated whole blood, was obtained by cardiac puncture from wild-type, annexin I-deficient (26), and C1q-deficient (27) mice on a C57BL/6 background.”
BackgroundMethodInfluentialMonogenic lupus: Dissecting heterogeneity
Omarjee, O., Picard, C., Frachette, C., Moreews, M., Rieux‐Laucat, F., Soulas-Sprauel, P., Viel, S., Lega, J., Bader‐Meunier, B., Walzer, T., et al. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102361 · Cited by 138
Apoptosis: the quiet death silences the immune system
Sun, E., & Shi, Y. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00164-4 · Cited by 145
“Currently, it has been shown that complement, especially C1q, participates in the clearance of apoptotic cells and deficiency in C1q not only causes autoimmune responses in SLE patients and SLE-like mice, but also helps develop glomerulonephritis (Botto et al., 1998).”
BackgroundChromatin breakdown during necrosis by serum Dnase1 and the plasminogen system
Napirei, M., Wulf, S., & Mannherz, H. G. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20267 · Cited by 134
The complement cascade as a mediator of tissue growth and regeneration
Rutkowski, M. J., Sughrue, M. E., Kane, A. J., Ahn, B. J., Fang, S., & Parsa, A. T. (2010) · Inflammation Research · doi:10.1007/s00011-010-0220-6 · Cited by 133
Persistence of apoptotic cells without autoimmune disease or inflammation in CD14−/− mice
Devitt, A., Parker, K. G., Ogden, C. A., Oldreive, C., Clay, M. F., Melville, L. A., Bellamy, C. O., Lacy-Hulbert, A., Gangloff, S. C., Goyert, S. M., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200410057 · Cited by 135
“…circumstances, apoptotic cell engulfment may be immunostimulatory, and the persistence of apoptotic cells is associated in specific mouse strains with the pathogenesis of autoimmune disease (Botto et al., 1998; Scott et al., 2001; Cohen et al., 2002; Szondy et al., 2003; Hanayama et al., 2004).”
BackgroundMethodInfluentialThe non-classical functions of the classical complement pathway recognition subcomponent C1q
Nayak, A., Ferluga, J., Tsolaki, A. G., & Kishore, U. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.03.012 · Cited by 145
Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn
Yu, C., Yen, T. S. B., Lowell, C. A., & DeFranco, A. L. (2001) · Current Biology · doi:10.1016/s0960-9822(00)00024-5 · Cited by 135
New insights into the resolution of inflammation
Gilroy, D. W., & Maeyer, R. P. H. D. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.05.003 · Cited by 156
Requirements for Apoptotic Cell Contact in Regulation of Macrophage Responses
Lucas, M., Stuart, L. M., Zhang, A., Hodivala-Dilke, K., Febbraio, M., Silverstein, R., Savill, J., & Lacy-Hulbert, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.4047 · Cited by 133
Baruah, P., Dumitriu, I. E., Peri, G., Russo, V., Mantovani, A., Manfredi, A. A., & Rovere-Querini, P. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0805445 · Cited by 131
“Deficiency of C1q has been shown to lead to a systemic lupus erythematosus (SLE)-like syndrome in mouse models and in humans [1].”
BackgroundGriffiths, M. R., Gasque, P., & Neal, J. W. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181996688 · Cited by 130
“The C pathway is important for apoptotic cell clearance because in C1q-deficient mice, apoptotic cells accumulate in the kidney, resulting in a glomerulonephritis with immune deposits (100).”
BackgroundCellular and nuclear degradation during apoptosis
He, B., Lü, N., & Zhou, Z. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.08.008 · Cited by 146
“Inefficient engulfment or degradation of apoptotic cells is associated with numerous chronicle inflammatory and autoimmune diseases [13-18].”
BackgroundImpaired Clearance of Apoptotic Cells in Chronic Inflammatory Diseases: Therapeutic Implications
Szondy, Z., Garabuczi, Ã., Joós, G., Tsay, G. J., & Sarang, Z. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00354 · Cited by 124
“totic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26).”
BackgroundApoptotic Cells Induced Signaling for Immune Homeostasis in Macrophages and Dendritic Cells
Trahtemberg, U., & Mevorach, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01356 · Cited by 132
“Biol Blood Marrow Transplant (2014) 20(1):58–65.”
Complement-dependent synapse loss and microgliosis in a mouse model of multiple sclerosis
Hammond, J. W., Bellizzi, M. J., Ware, C., Qiu, W. Q., Saminathan, P., Li, H., Luo, S., Ma, S. A., Li, Y., & Gelbard, H. A. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.03.004 · Cited by 134
HART, S. P., SMITH, J. R., & DRANSFIELD, I. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2003.02330.x · Cited by 126
Complement and innate immunity
Song, W.-C., Sarrias, M., & Lambris, J. D. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)80303-3 · Cited by 148
“Complement-mediated clearance of immune complexes is another type of interaction between complement and adaptive immunity with serious pathoŽphysiological implications Atkinson, 1988; Morgan .and Walport, 1991; Botto et al., 1998 .”
BackgroundScavenger receptors: diverse activities and promiscuous binding of polyanionic ligands
Platt, N., & Gordon, S. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90156-9 · Cited by 142
Immune complex-mediated tissue injury: a multistep paradigm
Jancar, S., & Crespo, M. S. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.11.007 · Cited by 128
Mackin, S., Desai, P., Whitener, B. M., Karl, C. E., Liu, M., Baric, R. S., Edwards, D. K., Chicz, T. M., McNamara, R. P., Alter, G., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01359-1 · Cited by 128
Metadata
- Authors
- Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J.
- Affiliations
- Imperial College London (GB)
- Institute of Medical Microbiology and Hygiene (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Walport, Mark J.
- Venue
- Nature Genetics
- Published
- 1998-05
- Volume
- 19
- Issue
- 1
- Pages
- 56-59
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2067217824
- Cited by
- 1,434
- References
- 21
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 22 · 2023: 18 · 2022: 27 · 2021: 29 · 2020: 20 · 2019: 39 · 2018: 29 · 2017: 37 · 2016: 27 · 2015: 36 · 2014: 47 · 2013: 39 · 2012: 62
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- C1q deficiency, glomerulonephritis, apoptotic bodies, systemic lupus erythematosus, classical complement pathway, autoimmunity, autoantibodies, efferocytosis, genetic background effects, immune deposits
- MeSH terms
- Animals, Antibodies, Antinuclear, Autoantigens, Crosses, Genetic, Glomerulonephritis, Homozygote, Kidney Glomerulus, Microscopy, Electron, Complement C1q, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.